CERVIX | CERVICAL SCREENING [ISSN 1804-087X]
česky | english | sitemap


PARTNERS AND EXPERT GUARANTEE
 
Czech Gynaecological and Obstetrical Society | Ministry of Health | Institute of Biostatistics and Analyses, Masaryk University
GRANT SUPPORT OF THE PROJECT
 
GlaxoSmithKline     Roche |

Other sources of information
Cervical cytology (in Czech)www.cipek.cz
Cervical cytology
 
Cancer Screening in the European Unionec.europa.eu
Cancer Screening in the European Union (2017)
[ 10,6 MB]
 
SVOD - Epidemiology of malignant tumours in the Czech Republicwww.svod.cz
Epidemiology of malignant tumours
in the Czech Republic
 
NCI Bethesda System
HPV College

 

News for health professionals

Epidemiology of cervical cancer Screening process References

Archive

Year: 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008


Study confirms HPV genotypes responsible for majority of cervical cancers worldwide
19.10.2010 ecancermedicalscience | More information...

Eight human papillomavirus (HPV) types (16, 18, 45, 33, 31, 52, 58, and 35) are responsible for over 90% of all cervical cancer cases worldwide, and should be the target of the next generation vaccines, according to the largest study of HPV genotypes to date, published Online First in The Lancet Oncology.

Combination of drug and radiotherapy treatment cuts risk of death from cervical cancer
20.8.2010 ecancermedicalscience | More information...

Dr Paul Symonds from the Department of Cancer Studies and Molecular Medicine at the University of Leicester, UK, has demonstrated that the use of a particular drug in collaboration with radiotherapy gives significantly better results than radiotherapy alone.

Summary of the European Guidelines for Quality Assurance in Cervical Cancer Screening - 2nd Edition
3.5.2010 IBA MU | More information...

Summary of the European Guidelines for Quality Assurance in Cervical Cancer Screening - 2nd Edition was published in Annals of Oncology. The article summarizes fundamental points and principles of the document, which was published in 2008 and comprises 250 pages divided into seven chapters prepared by 48 authors and contributors.

HPV test picks up more abnormal cell changes than regular smear test
30.4.2010 Cancer Research UK | More information...

Two studies suggest that testing for the human papillomavirus (HPV) - the major cause of cervical cancer - could be used in national cervical cancer screening programmes.

Debate over role of HPV test in cervical screening
23.3.2010 Cancer Research UK | More information...

Testing for the human papillomavirus (HPV) - the major cause of cervical cancer - may not help to identify women who are at risk of the disease, a new UK study suggests.

Home-testing kits could help to detect HPV in women who do not attend cervical screening
16.3.2010 Cancer Research UK | More information...

More cases of human papillomavirus (HPV) infection - the major cause of cervical cancer - could be detected if home-testing kits were given to women who cannot attend conventional cervical screening, a Dutch study has found.


Back